share_log

Evolus, Inc. (NASDAQ:EOLS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Evolus, Inc. (NASDAQ:EOLS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Evolus公司(納斯達克股票代碼:EOLS)剛剛公佈了第二季度收益:分析師對該股的看法是否有所改變?
Simply Wall St ·  08/03 21:13

It's been a pretty great week for Evolus, Inc. (NASDAQ:EOLS) shareholders, with its shares surging 13% to US$13.86 in the week since its latest quarterly results. The results were mixed overall, with revenues slightly ahead of analyst estimates at US$67m. Statutory losses by contrast were 8.0% larger than predictions at US$0.18 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Evolus在最新季度業績發佈後的一週股價上漲了13%,至13.86美元,股東們的一週表現相當不錯。業績總體上是波動的,營業收入略高於分析師的預估,達到了6700萬美元。相比之下,法定虧損額爲每股0.18美元,比預估值高8%。通常分析師會在每個季度業績發佈後更新他們的預測,我們可以從他們的預估中判斷他們對該公司的觀點是否有改變或是否有任何新的潛在問題。因此,我們收集了最新的業績後的預測,看看未來一年的前景。

big
NasdaqGM:EOLS Earnings and Revenue Growth August 3rd 2024
EOLS納斯達克股市將在2024年8月3日獲得盈利和營收增長

After the latest results, the seven analysts covering Evolus are now predicting revenues of US$267.1m in 2024. If met, this would reflect a decent 13% improvement in revenue compared to the last 12 months. Losses are supposed to decline, shrinking 18% from last year to US$0.69. Before this earnings announcement, the analysts had been modelling revenues of US$263.2m and losses of US$0.69 per share in 2024.

最新業績發佈後,覆蓋Evolus的7位分析師預測他們2024年的營業收入將達到2.671億美元。如果實現,相較於過去12個月,這將反映出13%的不錯改善。預計虧損將下降,從去年的0.84美元縮減18%至0.69美元。此前分析師預測2024年的營業收入爲2.632億美元,虧損爲每股0.69美元。

As a result there was no major change to the consensus price target of US$22.43, implying that the business is trading roughly in line with expectations despite ongoing losses. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Evolus, with the most bullish analyst valuing it at US$27.00 and the most bearish at US$16.00 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

因此,一致價格目標爲22.43美元,說明儘管虧損仍在持續,該公司的業務仍在符合預期。僅關注一個價格目標可能不明智,因爲一致目標實際上是分析師價格目標的平均值。因此,一些投資者喜歡查看預估範圍,以了解公司估值的任何不同看法。Evolus存在一些不同看法,其中最看好的分析師將其估值爲27.00美元,看淡的最多隻給了16.00美元股票。分析師並不全都對該股票的未來持相同看法,但預估範圍仍相對較窄,這表明其未來發展的結果可能並不完全不可預知。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Evolus' revenue growth is expected to slow, with the forecast 27% annualised growth rate until the end of 2024 being well below the historical 40% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 9.6% annually. So it's pretty clear that, while Evolus' revenue growth is expected to slow, it's still expected to grow faster than the industry itself.

現在審視大局,我們可以通過將預測與過去業績和行業增長預估進行比較來理解這些預測的意義。我們將強調Evolus的營業收入增長預估將放緩,到2024年底的預估年化增長率爲27%,遠低於過去五年的40%年化增長。同行業的其他受分析師關注的公司預計將以9.6%的年複合增長率增長其營收。因此,儘管Evolus的營業收入增長預計將放緩,但它仍預計將比該行業本身增長更快。

The Bottom Line

最重要的事情是分析師增加了它對下一年每股虧損的估計。令人欣慰的是,營收預測未發生重大變化,業務仍有望比整個行業增長更快。共識價格目標穩定在28.50美元,最新估計不足以對價格目標產生影響。

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at US$22.43, with the latest estimates not enough to have an impact on their price targets.

最明顯的結論是,分析師未對明年的虧損做出任何更改。令人高興的是,營收預測沒有任何重大變化,該業務仍預計將比更廣泛的行業增長得更快。一致價格目標僅保持在22.43美元,最新的預估還不足以對價格目標產生影響。

With that in mind, we wouldn't be too quick to come to a conclusion on Evolus. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Evolus analysts - going out to 2026, and you can see them free on our platform here.

基於此,我們不應過快地對Evolus做出結論。長遠的盈利能力比明年的利潤要重要得多。我們有多位Evolus分析師的估計,涵蓋到2026年,您可以在我們的平台免費查看它們。

Plus, you should also learn about the 2 warning signs we've spotted with Evolus .

此外,您還應該了解我們發現的關於Evolus的2個警示信號。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論